Evelo Biosciences, Inc. (EVLO)

Evelo Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cost of Revenue	2.41	0	0	0	0	0
Gross Profit	-2.41	0	0	0	0	0
Selling, General & Admin	20.85	29.91	31.75	22.27	23.23	18.22
Research & Development	53.48	78.55	83.64	69.62	63.13	39.89
Other Operating Expenses	0.68	0.06	0.49	-1.37	1.08	1.16
Operating Expenses	74.34	108.47	115.4	91.89	86.36	58.1
Operating Income	-76.74	-108.47	-115.4	-91.89	-86.36	-58.1
Interest Income	0	0	0	0	0	0
Interest Expense	3.16	4.67	3.61	-2.11	1.05	1.56
Other Expense / Income	1.52	0.46	2.74	3.48	-1.93	-2.72
Pretax Income	-81.44	-113.6	-121.75	-93.26	-85.47	-56.95
Income Tax	0.94	0.93	0.43	0.41	0.19	-3.09
Net Income	-82.35	-114.53	-122.18	-93.67	-85.66	-53.85
Shares Outstanding (Basic)	17	4	3	2	2	1
Shares Outstanding (Diluted)	17	4	3	2	2	1
Shares Change	221.78%	64.75%	34.02%	23.25%	46.46%	483.10%
EPS (Basic)	-13.35	-26.28	-46.18	-47.45	-53.49	-49.25
EPS (Diluted)	-13.35	-26.28	-46.18	-47.45	-53.49	-49.25
Free Cash Flow	-73.99	-101.86	-98.24	-74.38	-75.01	-52.74
Free Cash Flow Per Share	-4.26	-23.37	-37.14	-37.68	-46.84	-48.23
EBITDA	-73.56	-108.41	-114.91	-91.89	-86.36	-58.1
Depreciation & Amortization	1.56	2.06	2.22	2.03	1.76	1.94
EBIT	-75.12	-110.47	-117.13	-93.91	-88.12	-60.04

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.